Cabot (NYSE:CBT) Releases FY 2027 Earnings Guidance

by · The Cerbat Gem

Cabot (NYSE:CBT – Get Free Report) updated its FY 2027 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 6.150-6.750 for the period, compared to the consensus estimate of 7.030.

Cabot Trading Up 1.6%

NYSE CBT opened at $75.64 on Tuesday. The company has a market cap of $3.90 billion, a price-to-earnings ratio of 21.31, a P/E/G ratio of 8.68 and a beta of 0.83. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53. The business has a 50 day moving average price of $77.79 and a 200-day moving average price of $79.52. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48.

Cabot (NYSE:CBT – Get Free Report) last issued its earnings results on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.06. Cabot had a return on equity of 20.29% and a net margin of 5.23%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $927.29 million. During the same period in the prior year, the firm earned $1.70 earnings per share. Cabot’s revenue for the quarter was up 12.2% on a year-over-year basis. As a group, equities analysts expect that Cabot will post 6.35 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, October 11th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a report on Friday, August 21st. Truist Financial set a $100.00 price objective on shares of Cabot in a research note on Wednesday, August 5th. JPMorgan Chase & Co. lifted their price objective on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Finally, UBS Group reduced their price objective on shares of Cabot from $92.00 to $86.00 and set a “neutral” rating for the company in a report on Monday, October 5th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Cabot has a consensus rating of “Hold” and a consensus target price of $87.80.

View Our Latest Report on Cabot

Insider Buying and Selling

In other Cabot news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the transaction, the chief executive officer owned 404,134 shares of the company’s stock, valued at $34,351,390. This trade represents a 25.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In the last ninety days, insiders have sold 229,597 shares of company stock valued at $19,646,746. Company insiders own 3.08% of the company’s stock.

Cabot Company Profile

(Get Free Report)

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.

Featured Stories